Atlas Trials

The Impact of the Routine Aminophylline Administration Following Regadenoson Stress on SPECT Myocardial Perfusion

Clinical trial NCT01655524 · WITHDRAWN

Trial details

NCT number
NCT01655524
Sponsor
Rush University Medical Center
Status
WITHDRAWN
Phase
Phase 4
Study type
INTERVENTIONAL
Coronary Artery Disease
Start date
2012-07-01
Primary completion
2014-07-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.